Scarica l'app Stockscreener
0.9338
2.87%
-0.0276
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.9614
Aprire:
$0.94
Volume 24 ore:
65,142
Relative Volume:
1.36
Capitalizzazione di mercato:
$6.35M
Reddito:
-
Utile/perdita netta:
$22.68M
Rapporto P/E:
1.7619
EPS:
0.53
Flusso di cassa netto:
$-1.94M
1 W Prestazione:
-2.73%
1M Prestazione:
-6.57%
6M Prestazione:
-45.07%
1 anno Prestazione:
-38.16%
Intervallo 1D:
$0.93
$0.9799
Intervallo di 1 settimana:
$0.9231
$1.00
Portata 52W:
$0.80
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Nome
Pharmacyte Biotech Inc
Settore
Industria
Telefono
(917) 595.2850
Indirizzo
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Confronta PMCB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.40 | 2.19B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.45 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.41 | 111.01M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3762 | 672.88M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.1699 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Borsa (PMCB) Ultime notizie
Will PharmaCyte Biotech Inc. continue its uptrendMarket Activity Recap & Target Return Focused Stock Picks - Newser
Understanding PharmaCyte Biotech Inc.’s price movementJuly 2025 Sector Moves & Risk Controlled Stock Alerts - Newser
Exit strategy if you’re trapped in PharmaCyte Biotech Inc.Treasury Yields & Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for PharmaCyte Biotech Inc.Gap Down & Verified Momentum Stock Watchlist - Newser
Published on: 2025-09-03 05:40:32 - Newser
Order flow analysis tools used on PharmaCyte Biotech Inc.Trade Exit Report & Verified Swing Trading Watchlists - Newser
Detecting price anomalies in PharmaCyte Biotech Inc. with AIQuarterly Profit Review & Stock Portfolio Risk Control - Newser
Is PharmaCyte Biotech Inc. meeting your algorithmic filter criteriaWeekly Trade Review & Step-by-Step Trade Execution Guides - Newser
What data driven models say about PharmaCyte Biotech Inc.’s futureDollar Strength & Fast Moving Stock Trade Plans - Newser
Applying Elliott Wave Theory to PharmaCyte Biotech Inc.Dollar Strength & High Return Trade Opportunity Guides - Newser
PharmaCyte Biotech Boosts Stake in TNF Pharmaceuticals Amid Groundbreaking Computing Platform Partnership - AInvest
Chart based exit strategy for PharmaCyte Biotech Inc.Bear Alert & AI Powered Buy/Sell Recommendations - Newser
Pattern recognition hints at PharmaCyte Biotech Inc. upsideWeekly Trend Recap & Technical Confirmation Alerts - Newser
Applying big data sentiment scoring on PharmaCyte Biotech Inc.2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Ranking PharmaCyte Biotech Inc. among high performing stocks via tools2025 AllTime Highs & Safe Capital Growth Tips - Newser
Is PharmaCyte Biotech Inc. stock trending bullishInflation Watch & Proven Capital Preservation Tips - khodrobank.com
Can you recover from losses in PharmaCyte Biotech Inc.July 2025 EndofMonth & Verified Technical Signals - Newser
Is PharmaCyte Biotech Inc. stock a top performer YTDQuarterly Trade Review & AI Forecast Swing Trade Picks - khodrobank.com
Leading vs lagging indicators on PharmaCyte Biotech Inc. performanceJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
PharmaCyte Biotech Inc increases stake in TNF Pharmaceuticals by $3 million - MarketScreener
Published on: 2025-09-02 10:21:28 - Newser
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications | PMCB Stock News - GuruFocus
PharmaCyte’s Strategic Bet on TNF Pharmaceuticals and LightSolver’s Light Speed Computing Technology: A Convergence of Biotech and Blockchain for Long-Term Value Creation - AInvest
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - The Globe and Mail
Does PharmaCyte Biotech Inc. stock have upside surprise potentialEarnings Recap Report & High Yield Equity Trading Tips - khodrobank.com
Will PharmaCyte Biotech Inc. benefit from geopolitical trendsTrade Risk Summary & High Return Stock Watch Alerts - khodrobank.com
What earnings revisions data tells us about PharmaCyte Biotech Inc.July 2025 Short Interest & AI Enhanced Execution Alerts - Newser
Can PharmaCyte Biotech Inc. continue delivering strong returnsGDP Growth & Verified Short-Term Plans - khodrobank.com
Should you avoid PharmaCyte Biotech Inc. stock right nowJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - khodrobank.com
Is PharmaCyte Biotech Inc. stock risky to hold nowJuly 2025 Big Picture & Daily Profit Focused Screening - khodrobank.com
Using economic indicators to assess PharmaCyte Biotech Inc. potentialMarket Activity Summary & Low Risk High Win Rate Stock Picks - Newser
PharmaCyte Biotech Inc. At Decision Level — Rebound or Resistance getLinesFromResByArray error: size == 0 - thegnnews.com
PharmaCyte Biotech Inc. Breakout Confirmed by Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
What moving averages say about PharmaCyte Biotech Inc.2025 Key Lessons & Growth Focused Entry Reports - Newser
Signal strength of PharmaCyte Biotech Inc. stock in tech scannersQuarterly Earnings Report & Real-Time Volume Analysis - Newser
Published on: 2025-08-31 14:20:15 - Newser
Is PharmaCyte Biotech Inc. stock ready for a breakout2025 Price Momentum & Risk Controlled Daily Trade Plans - Newser
Pharmacyte Biotech Inc Azioni (PMCB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):